Merck Pre-Tax Income 2010-2024 | MKKGY
Merck annual/quarterly pre-tax income history and growth rate from 2010 to 2024. Pre-tax income can be defined as company's earnings or loss before taxes on income have been accounted for.
- Merck pre-tax income for the quarter ending June 30, 2024 was $0.845B, a 13.28% decline year-over-year.
- Merck pre-tax income for the twelve months ending June 30, 2024 was $3.531B, a 14% decline year-over-year.
- Merck annual pre-tax income for 2023 was $3.771B, a 16.52% decline from 2022.
- Merck annual pre-tax income for 2022 was $4.517B, a 2.71% decline from 2021.
- Merck annual pre-tax income for 2021 was $4.642B, a 54.53% increase from 2020.
Merck Annual Pre-Tax Income
(Millions of US $) |
| 2023 |
$3,771 |
| 2022 |
$4,517 |
| 2021 |
$4,642 |
| 2020 |
$3,004 |
| 2019 |
$1,943 |
| 2018 |
$1,725 |
| 2017 |
$2,514 |
| 2016 |
$2,384 |
| 2015 |
$1,650 |
| 2014 |
$2,070 |
| 2013 |
$1,844 |
| 2012 |
$912 |
| 2011 |
$1,186 |
| 2010 |
$12,338 |
| 2009 |
$10,807 |
Merck Quarterly Pre-Tax Income
(Millions of US $) |
| 2024-06-30 |
$845 |
| 2024-03-31 |
$976 |
| 2023-12-31 |
$690 |
| 2023-09-30 |
$1,020 |
| 2023-06-30 |
$975 |
| 2023-03-31 |
$1,086 |
| 2022-12-31 |
$849 |
| 2022-09-30 |
$1,196 |
| 2022-06-30 |
$1,194 |
| 2022-03-31 |
$1,278 |
| 2021-12-31 |
$1,135 |
| 2021-09-30 |
$1,171 |
| 2021-06-30 |
$1,151 |
| 2021-03-31 |
$1,186 |
| 2020-12-31 |
$650 |
| 2020-09-30 |
$1,245 |
| 2020-06-30 |
$428 |
| 2020-03-31 |
$681 |
| 2019-12-31 |
$489 |
| 2019-09-30 |
$526 |
| 2019-06-30 |
$627 |
| 2019-03-31 |
$302 |
| 2018-12-31 |
$268 |
| 2018-09-30 |
$506 |
| 2018-06-30 |
$391 |
| 2018-03-31 |
$561 |
| 2017-12-31 |
$190 |
| 2017-09-30 |
$983 |
| 2017-06-30 |
$613 |
| 2017-03-31 |
$729 |
| 2016-12-31 |
$359 |
| 2016-09-30 |
$680 |
| 2016-06-30 |
$485 |
| 2016-03-31 |
$860 |
| 2015-12-31 |
$175 |
| 2015-09-30 |
$537 |
| 2015-06-30 |
$509 |
| 2015-03-31 |
$428 |
| 2014-12-31 |
$446 |
| 2014-09-30 |
$493 |
| 2014-06-30 |
$536 |
| 2014-03-31 |
$594 |
| 2013-12-31 |
$280 |
| 2013-09-30 |
$570 |
| 2013-06-30 |
$544 |
| 2013-03-31 |
$450 |
| 2012-12-31 |
$3,646 |
| 2012-09-30 |
$325 |
| 2012-06-30 |
$-60 |
| 2012-03-31 |
$3,274 |
| 2011-12-31 |
$3,311 |
| 2011-09-30 |
$3,585 |
| 2011-06-30 |
$-140 |
| 2011-03-31 |
$3,505 |
| 2010-12-31 |
$6,479 |
| 2010-09-30 |
$373 |
| 2010-06-30 |
$2,695 |
| 2010-03-31 |
$2,791 |
| 2009-12-31 |
$2,983 |
| 2009-09-30 |
$2,778 |
| 2009-06-30 |
$2,590 |
| 2009-03-31 |
$2,456 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-DRUGS |
$21.306B |
$22.719B |
|
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
|
